{
  "symbol": "AUROPHARMA.NS",
  "period": "annual",
  "data": [
    {
      "ticker": "AUROPHARMA.NS",
      "date": "2021-03-31",
      "quarter": "Q1 2021",
      "fiscal_year": 2021,
      "revenue": null,
      "gross_profit": null,
      "operating_income": null,
      "ebitda": null,
      "net_income": null,
      "diluted_eps": null,
      "total_assets": null,
      "total_liabilities": null,
      "total_equity": null,
      "total_debt": null,
      "cash_and_equivalents": null,
      "current_assets": null,
      "current_liabilities": null,
      "operating_cash_flow": null,
      "investing_cash_flow": null,
      "financing_cash_flow": null,
      "free_cash_flow": null,
      "capex": null,
      "pe_ratio": 20.789072,
      "peg_ratio": null,
      "pb_ratio": 2.030345,
      "ps_ratio": 2.1883788,
      "price_target_high": 1640.0,
      "price_target_low": 730.0,
      "price_target_avg": 1295.9642,
      "promoter_holding": 0.5411,
      "institutional_holding": 0,
      "eps_estimate": null,
      "dividends": 4.0,
      "splits": 2.0,
      "buybacks": 580801623,
      "debt_to_equity": null,
      "current_ratio": null,
      "operating_margin": null,
      "net_profit_margin": null,
      "roe": null,
      "roa": null,
      "debt_to_fcf_ratio": null,
      "ebitda_margin": null
    },
    {
      "ticker": "AUROPHARMA.NS",
      "date": "2022-03-31",
      "quarter": "Q1 2022",
      "fiscal_year": 2022,
      "revenue": 233665500000.0,
      "gross_profit": 125513700000.0,
      "operating_income": 33002700000.0,
      "ebitda": 45361000000.0,
      "net_income": 26481500000.0,
      "diluted_eps": null,
      "total_assets": 339217200000.0,
      "total_liabilities": 93476700000.0,
      "total_equity": 245740500000.0,
      "total_debt": 32789600000.0,
      "cash_and_equivalents": 41625100000.0,
      "current_assets": 181226900000.0,
      "current_liabilities": 81559800000.0,
      "operating_cash_flow": 50164800000.0,
      "investing_cash_flow": -32115600000.0,
      "financing_cash_flow": -29692700000.0,
      "free_cash_flow": 23118400000.0,
      "capex": -27046400000.0,
      "pe_ratio": 20.789072,
      "peg_ratio": null,
      "pb_ratio": 2.030345,
      "ps_ratio": 2.1883788,
      "price_target_high": 1640.0,
      "price_target_low": 730.0,
      "price_target_avg": 1295.9642,
      "promoter_holding": 0.5411,
      "institutional_holding": 0,
      "eps_estimate": null,
      "dividends": 4.0,
      "splits": 2.0,
      "buybacks": 580801623,
      "debt_to_equity": 0.13343181119921219,
      "current_ratio": 2.2220125601092695,
      "operating_margin": 14.123907893976645,
      "net_profit_margin": 11.33308083563898,
      "roe": 10.776204980457027,
      "roa": 7.806650134486105,
      "debt_to_fcf_ratio": 1.4183334486815697,
      "ebitda_margin": 19.412793073859856
    },
    {
      "ticker": "AUROPHARMA.NS",
      "date": "2023-03-31",
      "quarter": "Q1 2023",
      "fiscal_year": 2023,
      "revenue": 246171300000.0,
      "gross_profit": 127174300000.0,
      "operating_income": 25376000000.0,
      "ebitda": 39860300000.0,
      "net_income": 19275000000.0,
      "diluted_eps": null,
      "total_assets": 398899900000.0,
      "total_liabilities": 130381400000.0,
      "total_equity": 268518500000.0,
      "total_debt": 52862100000.0,
      "cash_and_equivalents": 43962900000.0,
      "current_assets": 215456700000.0,
      "current_liabilities": 114937800000.0,
      "operating_cash_flow": 23867500000.0,
      "investing_cash_flow": -39777500000.0,
      "financing_cash_flow": 18144100000.0,
      "free_cash_flow": -3336500000.0,
      "capex": -27204000000.0,
      "pe_ratio": 20.789072,
      "peg_ratio": null,
      "pb_ratio": 2.030345,
      "ps_ratio": 2.1883788,
      "price_target_high": 1640.0,
      "price_target_low": 730.0,
      "price_target_avg": 1295.9642,
      "promoter_holding": 0.5411,
      "institutional_holding": 0,
      "eps_estimate": null,
      "dividends": 4.0,
      "splits": 2.0,
      "buybacks": 580801623,
      "debt_to_equity": 0.19686576530108726,
      "current_ratio": 1.8745504090038265,
      "operating_margin": 10.308269079295595,
      "net_profit_margin": 7.829913560191623,
      "roe": 7.178276357122508,
      "roa": 4.832039316129184,
      "debt_to_fcf_ratio": null,
      "ebitda_margin": 16.192098753997726
    },
    {
      "ticker": "AUROPHARMA.NS",
      "date": "2024-03-31",
      "quarter": "Q1 2024",
      "fiscal_year": 2024,
      "revenue": 287045000000.0,
      "gross_profit": 154682900000.0,
      "operating_income": 44415300000.0,
      "ebitda": 61399900000.0,
      "net_income": 31729700000.0,
      "diluted_eps": null,
      "total_assets": 450715100000.0,
      "total_liabilities": 152207100000.0,
      "total_equity": 298508000000.0,
      "total_debt": 66476300000.0,
      "cash_and_equivalents": 33934800000.0,
      "current_assets": 242056300000.0,
      "current_liabilities": 121991300000.0,
      "operating_cash_flow": 24345200000.0,
      "investing_cash_flow": -42559500000.0,
      "financing_cash_flow": 8004200000.0,
      "free_cash_flow": -11269800000.0,
      "capex": -35615000000.0,
      "pe_ratio": 20.789072,
      "peg_ratio": null,
      "pb_ratio": 2.030345,
      "ps_ratio": 2.1883788,
      "price_target_high": 1640.0,
      "price_target_low": 730.0,
      "price_target_avg": 1295.9642,
      "promoter_holding": 0.5411,
      "institutional_holding": 0,
      "eps_estimate": null,
      "dividends": 4.0,
      "splits": 2.0,
      "buybacks": 580801623,
      "debt_to_equity": 0.22269520414863253,
      "current_ratio": 1.98420952969597,
      "operating_margin": 15.47328816039297,
      "net_profit_margin": 11.053911407619015,
      "roe": 10.62943036702534,
      "roa": 7.039857328942385,
      "debt_to_fcf_ratio": null,
      "ebitda_margin": 21.39033949380759
    },
    {
      "ticker": "AUROPHARMA.NS",
      "date": "2025-03-31",
      "quarter": "Q1 2025",
      "fiscal_year": 2025,
      "revenue": 313781300000.0,
      "gross_profit": 176366100000.0,
      "operating_income": 50480600000.0,
      "ebitda": 70978800000.0,
      "net_income": 34858800000.0,
      "diluted_eps": null,
      "total_assets": 497849700000.0,
      "total_liabilities": 171380400000.0,
      "total_equity": 326469300000.0,
      "total_debt": 82628700000.0,
      "cash_and_equivalents": 55689500000.0,
      "current_assets": 271624600000.0,
      "current_liabilities": 146823400000.0,
      "operating_cash_flow": 39246200000.0,
      "investing_cash_flow": -18758000000.0,
      "financing_cash_flow": 1197800000.0,
      "free_cash_flow": 14050700000.0,
      "capex": -25195500000.0,
      "pe_ratio": 20.789072,
      "peg_ratio": null,
      "pb_ratio": 2.030345,
      "ps_ratio": 2.1883788,
      "price_target_high": 1640.0,
      "price_target_low": 730.0,
      "price_target_avg": 1295.9642,
      "promoter_holding": 0.5411,
      "institutional_holding": 0,
      "eps_estimate": null,
      "dividends": 4.0,
      "splits": 2.0,
      "buybacks": 580801623,
      "debt_to_equity": 0.2530979176296209,
      "current_ratio": 1.8500089222835052,
      "operating_margin": 16.087829325711887,
      "net_profit_margin": 11.109266230970425,
      "roe": 10.677512403157051,
      "roa": 7.001872251806117,
      "debt_to_fcf_ratio": 5.880753272078971,
      "ebitda_margin": 22.620468460038886
    }
  ]
}